Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQJZW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,007
Award facts
- Contract value 100% obligated
- $18,007.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,007.17 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors. This is a competitively awarded, firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement needs supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Dupixent (dupilumab) is a biologic medication commonly prescribed for eczema, asthma, and allergic conditions, reflecting the company's role in supplying specialty pharmaceuticals to federal customers. This delivery order represents one of numerous transactions under the larger IDC vehicle, demonstrating AmerisourceBergen's established capacity to meet federal pharmaceutical supply requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB25FQJZW?
SPE2DB25FQJZW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FQJZW worth?
The government has obligated $18,007 on SPE2DB25FQJZW.
Is contract SPE2DB25FQJZW an order under another contract?
Yes. SPE2DB25FQJZW is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJZW competed?
The extent of competition for SPE2DB25FQJZW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award